Will brain after status epilepticus be history in 2010?

Progress in Brain Research

Volumn 135, Issue , 2002, Pages 471-478

  Treiman, David M ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DIAZEPAM; LORAZEPAM; NEUROPROTECTIVE AGENT; PHENOBARBITAL; PHENYTOIN; PLACEBO; VALPROIC ACID;

ANIMAL MODEL; ANTICONVULSANT THERAPY; BRAIN ATROPHY; BRAIN INJURY; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EMERGENCY TREATMENT; EPILEPSY; EPILEPTIC STATE; HUMAN; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME; ANIMAL; CHRONIC BRAIN DISEASE; DISEASE MODEL; FORECASTING; PATHOLOGY; REVIEW;

ANIMALS; ANTICONVULSANTS; BRAIN DAMAGE, CHRONIC; DISEASE MODELS, ANIMAL; FORECASTING; HUMANS; STATUS EPILEPTICUS;

EID: 0036053841     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(02)35044-1     Document Type: Conference Paper

References (45)

1. Alabadi, J.A., Thibault, J.L., Pinard, E., Seylaz, J. and Lasbennes, F. (1999) 7-Nitroindazole, a selective inhibitor of nNOS, increases hippocampal extracellular glutamate concentration in status epilepticus induced by kainic acid in rats. Brain Res., 839: 305-312.
2. Chamberlain, J.M., Altieri, M.A., Futterman, C., Young, G.M., Ochsenschlager, D.W. and Waisman, Y. (1997) A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr. Emerg. Care, 13: 92-94.
3. Choi, D.W. (1987) Ionic dependence of glutamate neurotoxicity. J. Neurosci., 7: 369-379.
4. Choi, D.W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1: 623-634.
5. DeLorenzo, R.J., Hauser, W.A., Towne, A.R., Boggs, J.G., Pellock, J.M., Penberthy, L., Garnett, L., Fortner, C.A., Ko, D. and Pellock, J. (1996) A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology, 46: 1029-1035.
6. Doppenberg, E.M., Choi, S.C. and Bullock, R. (1997) Clinical trials in traumatic brain injury. What can we learn from previous studies?. Ann. N.Y. Acad. Sci., 825: 305-322.
7. Dugan, L.L. and Choi, D.W. (1999) Hypoxic-ischemic brain injury and oxidative stress. In: G.J. Siegel, B.W. Agranoff, R.W. Albers, S.K. Fisher and M.D. Uhler (Eds.), Basic Neurochemistry: Molecular, Cellular and Medical Aspects, 6th ed., ch. 34. Lippincott-Raven, Philadelphia, PA, pp. 711-729.
8. Faden, A.I., Demediuk, P., Panter, S.S. and Vink, R. (1989) The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science, 244: 798-800.
9. Fujikawa, D.G. (1996) The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus. Brain Res., 725: 11-22.
10. Garthwaite, G., Hajos, F. and Garthwaite, J. (1986) Ionic requirements for neurotoxic effects of excitatory amino acid analogues in rat cerebellar slices. Neuroscience, 18: 437-447.
11. Gruenthal, M. (1998) Electroencephalographic and histological characteristics of a model of limbic status epilepticus permitting direct control over seizure duration. Epilepsy Res., 29: 221-232.
12. Handforth, A. and Treiman, D.M. (1994) A new, nonpharmacologic model of convulsive status epilepticus induced by electrical stimulation: Behavioral/electroencephalographic observations and response to phenytoin and phenobarbital. Epilepsy Res., 19: 15-25.
13. Hayashi, T. (1954) Effects of sodium glutamate on the nervous system. Keio J. Med., 3: 183-192.
14. Katayama, Y., Becker, D.P., Tamura, T. and Hovda, D.A. (1990) Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J. Neurosurg., 73: 889-900.
15. Kim, J.-M., Walton, N.Y. and Treiman, D.M. (1997) EEG patterns of high-dose pilocarpine-induced status epilepticus in rats (abstr.). Epilepsia, 38(Suppl. 8): 225-226.
16. Koplovitz, I. and Skvorak, J.P. (1998) Electrocorticographic changes during generalized convulsive status epilepticus in soman intoxicated rats. Epilepsy Res., 30: 159-164.
17. Lehmann, A., Hagberg, H., Jacobson, I. and Hamberger, A. (1985) Effects of status epilepticus on extracellular amino acids in the hippocampus. Brain Res., 359: 147-151.
18. Leppik, I.E., Derivan, A.T., Homan, R.W., Walker, J., Ramsay, R.E. and Patrick, B. (1983) Double-blind study of lorazepam and diazepam in status epilepticus. JAMA, 249: 1452-1454.
19. Logroscino, G., Hesdorffer, D.C., Cascino, G., Annegers, J.F. and Hauser, W.A. (1997) Short-term mortality after a first episode of status epilepticus. Epilepsia, 38: 1344-1349.
20. Lothman, E.W., Bertram, E.H., Bekenstein, J.W. and Perlin, J.B. (1989) Self-sustaining limbic status epilepticus induced by 'continuous' hippocampal stimulation: Electrographic and behavioral characteristics. Epilepsy Res., 3: 107-119.
21. Lucas, D.R. and Newhouse, J.P. (1957) The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch. Ophthalmol., 58: 193-201.
22. McDonough Jr., J.H., Dochterman, L.W., Smith, C.D. and Shih, T.M. (1995) Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology, 16: 123-132.
23. McDonough, J.H. Jr., Capacio, B.R. and Shih, T.-.M. (2001) Benzodiazepine dosage necessary to terminate soman-induced seizures in a rhesus monkey model. Unpublished report presented at an Advanced Anticonvulsant System Focus Group Meeting, U.S. Army Medical Material Development Activity. Fort Detrick, MD July 17-18, 2001.
24. Mikati, M.A., Chronopoulos, A. and Holmes, G.L. (1992) Stages of kainic acid (KA)-induced status epilepticus (SE) in the prepubescent brain and response to phenobarbital (Ph) (abstr.). Neurology, 42(Suppl. 3): 364.
25. Nahorski, S.R. (1988) Inositol polyphosphates and neuronal calcium homeostasis. Trends Neurosci., 11: 444-448.
26. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1978) The Belmont Report: Ethical Principles and Guidelines for the Protection of Subjects of Research, DHEW Publication No. (OS) 78-0012, Appendix I, DHEW Publication No. (OS) 78-0013, Appendix II, DHEW Publication (OS) 78-0014, Washington, DC.
27. Olney, J.W. (1985) Excitatory transmitters and epilepsy-related brain damage. Int. Rev. Neurobiol., 27: 337-362.
28. Olney, J.W. and Sharpe, L.G. (1969) Brain lesions in an infant rhesus monkey treated with monosodium glutamate. Science, 166: 386-388.
29. Olney, J.W., Ho, O.L. and Rhee, V. (1971) Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp. Brain Res., 14: 61-76.
30. Olney, J.W., Collins, R.C. and Sloviter, R.S. (1986) Excitotoxic mechanisms of epileptic brain damage. Adv. Neurol., 44: 857-877.
31. Rothman, S.M., Thurston, J.H. and Hauhart, R.E. (1987) Delayed neurotoxicity of excitatory amino acids in vitro. Neuroscience, 22: 471-480.
32. Rowan, A.J. and Scott, D.F. (1970) Major status epilepticus: A series of 42 patients. Acta Neurol. Scand., 46: 573-584.
33. Scott, R.C., Besag, F.M. and Neville, B.G. (1999) Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: A randomised trial. Lancet, 353: 623-626.
34. Shaner, D.M., McCurdy, S.A., Herring, M.O. and Gabor, A.J. (1988) Treatment of status epilepticus: A prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology, 38: 202-207.
35. Treiman, D.M. (1998) Clinical trials for status epilepticus. Adv. Neurol., 76: 173-178.
36. Treiman, D.M., Walton, N.Y., Wickboldt, C. and DeGiorgio, C.M. (1987) Predictable sequence of EEG changes during generalized convulsive status epilepticus in man and three experimental models of status epilepticus in the rat (abstr.). Neurology, 7(Suppl. 1): 244.
37. Treiman, D.M., Walton, N.Y. and Kendrick, C. (1990) A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res., 5: 49-60.
38. Treiman, D.M., Meyers, P.D., Walton, N.Y. and DVA Status Epilepticus Cooperative Study Group (1992) Duration of generalized convulsive status epilepticus: Relationship to clinical symptomatology and response to treatment (abstr.). Epilepsia, 33(Suppl. 3): 66.
39. Treiman, D.M., Meyers, P.D., Walton, N.Y. and DVA Status Epilepticus Cooperative Study Group (1993) Factors that predict prognosis in generalized convulsive status epilepticus (abstr.). Epilepsia, 34(Suppl. 6): 30.
40. Treiman, D.M., Meyers, P.D., Walton, N.Y., Collins, J.F., Colling, C., Rowan, A.J., Handforth, A., Faught, E., Calabrese, V.P., Uthman, B.M., Ramsay, R.E. and Mamdani, M.B. (1998) A comparison of four treatments for generalized convulsive status epilepticus. N. Engl. J. Med., 339: 792-798.
41. Treiman, D.M., Walton, N.Y., Collins, J.F. and DVA Status Epilepticus Cooperative Study Group (2000) EEG pattern in generalized convulsive status epilepticus (GCSE) predicts response to treatment. Epilepsia, 41(Suppl. 7): 218.
42. Walton, N.Y. and Treiman, D.M. (1988) Experimental secondarily generalized convulsive status epilepticus induced by D,L-homocysteine thiolactone. Epilepsy Res., 2: 79-86.
43. Walton, N.Y. and Treiman, D.M. (1992) Valproic acid treatment of experimental status epilepticus. Epilepsy Res., 12: 199-205.
44. Walton, N.Y. and Treiman, D.M. (1995) Every seizure counts in status epilepticus: An experimental comparison of treatment after one and two generalized tonic-clonic seizures (abstr.). Epilepsia, 36(Suppl. 4): 45.
45. Walton, N.Y. and Treiman, D.M. (1996) Rational polytherapy in the treatment of status epilepticus. Epilepsy Res. Suppl., 11: 123-139.